Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). Issue 9 (31st July 2022)

• Record Type: Journal Article
• Authors: Maruyama, Dai; Iida, Shinsuke; Machida, Ryunosuke; Kusumoto, Shigeru; Fukuhara, Noriko; Yamauchi, Nobuhiko; Miyazaki, Kana; Yoshimitsu, Makoto; Kuroda, Junya; Tsukamoto, Norifumi; Tsujimura, Hideki; Usuki, Kensuke; Yamauchi, Takahiro; Utsumi, Takahiko; Mizuno, Ishikazu; Takamatsu, Yasushi; Nagata, Yasuyuki; Ota, Shuichi; Ohtsuka, Eiichi; Hanamura, Ichiro; Suzuki, Yasuhiro; Yoshida, Shinichiro; Yamasaki, Satoshi; Suehiro, Youko; Kamiyama, Yutaro; Fukuhara, Suguru; Tsukasaki, Kunihiro; Nagai, Hirokazu
• Is Part Of: Cancer science. Volume 113:Issue 9(2022)
• Page Start: 3267
• Page End: 3270
• Publication Date: 2022-07-31
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.15484
• Languages: English
• ISSNs: 1347-9032